|
Monsanto (NYSE: MON) is the
world's leading developer of bio-engineered seeds for everything
from cotton to eggplant. The company also markets a full-line of
herbicide products, including the popular Roundup brand, for
both lawn/garden and commercial applications.
Competitive Advantages: Whether it's large-acre
harvests of corn and soybeans or smaller crops such as tomatoes
and cucumbers, Monsanto has a full inventory of seeds that
enable farmers to squeeze more out of every acre.
These aren't your garden-variety fruit and vegetable seeds.
Years of genetic research have led to the development of
superior products that not only maximize yields, but also
protect against insects, herbicides, heat, disease and other
such threats.
As you might expect, customers are willing to pay premium prices
for these added traits. For example, a typical bag of
run-of-the-mill corn seeds sold for about $100 last year, while
a bag of Monsanto's "triple-stacked" bio seeds fetched $245.
Monsanto didn't just one-up the competition -- it virtually
created this entire industry from the ground up about ten years
ago. And with more than 280 million acres of
genetically-enhanced crops currently planted in two dozen
countries around the world, it's a huge market.
Of course, success has invited competition, but Monsanto's
research, production, and distribution capabilities are simply
unrivaled. In fact, other players like Dow Chemical and BASF
have sought out partnership agreements rather than try to beat
the company at its own game.
Special Offers
|
 |
Get Investor's Business Daily
FREE for two weeks.
Learn
More
|
|
 |
|
Risk free
trial of our live e-mini futures trading room.
Learn
More |

|
|
|
|
Catalyst(s):
Some governments and political groups have spoken out
against genetically modified seeds, but that resistance is
fading amid irrefutable evidence that these crops are
environmentally friendly and even have nutritional benefits.
In fact, the World Trade Organization has been pressuring
the European Union to lift certain restrictions.
Clearly, unlocking new markets will spell plenty of
potential opportunities for Monsanto. And this innovative
company is already preparing for a surge in demand. The firm
typically plows about 10% of its sales right back into
research and development. Right now, it's investing $2.6
million every single day on new traits, breeding, and
genomics work.
And those ambitious efforts have again borne fruit. On
Monday, federal regulators gave the green light for Monsanto
to begin distribution of its eagerly anticipated "SmartStax"
corn seeds. These next-generation seeds combine as many as
eight different traits (including above and below ground
pest protection) in a single tiny seed.
The new all-in-one seeds will be warmly welcomed by farmers
and are expected to be planted on up to 4 million acres
within the first year of availability. Thanks to certain
incentives, my staff and I feel that penetration for the new
product will expand rapidly to more than 60 million acres
over the next five years -- out of roughly 90 million acres
of corn nationwide.
SmartStax could also be headed for farms in Japan, Taiwan
and South Korea. But that isn't all the company has cooking.
Among other developments in the pipeline, Monsanto's
drought-resistant seeds are in the final phases of
development and could soon protect entire harvests from the
ravages of a severe drought.
These and other new product launches will deepen the firm's
cash flow stream and whip up excitement in the investment
community.
Valuation and Outlook: While grain prices will
fluctuate, demand for Monsanto's products is unwavering.
After all, whether soybeans sell for $7 per bushel or $12
per bushel, farmers will always be interested in maximizing
their output.
But odds are good that prices for agricultural commodities
will continue to strengthen.
First, rising global populations means there are millions of
new mouths to feed each year. At the same time, demand for
biofuels is further putting a strain on supplies -- ethanol
production ate up more than one-fourth of the nation's corn
harvest last year. Finally, rising incomes in emerging
markets have led to a profound change in dietary habits.
Specifically, we are eating much more meat these days. For
example, China's annual per capita meat consumption was 110
pounds last year, versus just 40 pounds back in 1980.
Animals consume far more grains than humans pound for pound,
so increased meat consumption has triggered huge demand for
livestock feed.
Food, fuel and feed -- three different groups all hungry for
the same crops. Unfortunately, the amount of arable land is
relatively fixed. That means farmers around the world will
be challenged to grow more from each acre of soil, and they
will need Monsanto's help to do so.
Through the first six months of 2009, sales have climbed to
a record $6.7 billion and earnings are up +19% over last
year's pace. Based on full-year profits of $4.50 per share,
the stock is currently trading at a forward P/E of just
under 19 -- well below the premium multiple of 49 it has
commanded on average over the past five years. Not
surprisingly, management is expecting its gross profits to
double in the U.S. and triple overseas by 2012.
Action to Take --> It's
no secret why Monsanto continues to grow like a prize
watermelon. The firm's seeds require fewer inputs (water,
fertilizer, etc.) and spit out more bushels per acre, so
farmers keep coming back for more.
If SmartStax proves to be even half as successful as
initially thought, MON should power its way back into
triple-digit territory.
Good Investing!
-- Nathan Slaughter
Editor
StreetAuthority
Market Advisor
|
Health Care Reform
Which of these health care
companies delivered an annualized +24.5%, about twice
the average historical return of the S&P, in the past 10
years, and is poised to add billions more to its bottom
line if Washington moves more people onto private
insurance?
A.)
Continucare CP (CNU)
B.)
Neostem Inc. (NBS)
C.)
Mednax (MD)
D.)
DaVita (DVA)
E.)
MDS Inc. (MDZ)
(Please click on one the
links above. After you make your choice, we'll show you
the correct answer on our web site.)
|
|
Visit this link to read additional articles from today's
leading market experts! |
|